| 1 |
ACTELION PHARMACEUTICALS US, INC. et al v. ALEMBIC PHARMACEUTICALS LIMITED et al |
2:23-cv-01902 |
D.N.J. |
|
|
|
|
| 2 |
ACTELION PHARMACEUTICALS US, INC. et al v. ALEMBIC PHARMACEUTICALS LIMITED et al |
2:23-cv-01902 |
D.N.J. |
|
|
|
|
| 3 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al |
1:18-cv-01762 |
D.Del. |
|
|
|
|
| 4 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al |
1:18-cv-01762 |
D.Del. |
|
|
|
|
| 5 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Alembic Pharmaceuticals Ltd. et al |
1:18-cv-01762 |
D.Del. |
|
|
|
|
| 6 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 7 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 8 |
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mankind Pharma Ltd. et al |
1:18-cv-01689 |
D.Del. |
|
|
|
|
| 9 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 10 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 11 |
Bayer Intellectual Property GMBH et al v. Taro Pharmaceutical Industries Ltd. et al |
1:17-cv-00462 |
D.Del. |
|
- 12 IP subsidiary of product company
- 8 Product company
|
|
|
| 12 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
| 13 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
| 14 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
| 15 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
| 16 |
Wyeth LLC et al v. Alembic Pharmaceuticals, Ltd. et al |
1:16-cv-01305 |
D.Del. |
|
|
|
|
| 17 |
Eli Lilly and Company et al v. Alembic Pharmaceuticals Ltd. et al |
1:16-cv-01120 |
E.D.Va. |
|
|
|
|
| 18 |
Eli Lilly and Company et al v. Alembic Pharmaceuticals Ltd. et al |
1:16-cv-01120 |
E.D.Va. |
|
|
|
|
| 19 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
| 20 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
| 21 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
| 22 |
AstraZeneca LP et al v. Alembic Pharmaceuticals LTD et al. |
1:15-cv-01003 |
D.Del. |
|
|
|
|
| 23 |
Forest Laboratories LLC et al v. Alembic Pharmaceuticals Ltd. et al |
1:15-cv-00158 |
D.Del. |
|
|
|
|
| 24 |
Forest Laboratories LLC et al v. Alembic Pharmaceuticals Ltd. et al |
1:15-cv-00158 |
D.Del. |
|
|
|
|
| 25 |
Forest Laboratories LLC et al v. Sigmapharm Laboratories LLC et al |
1:14-cv-01119 |
D.Del. |
|
|
|
|
| 26 |
Forest Laboratories LLC et al v. Sigmapharm Laboratories LLC et al |
1:14-cv-01119 |
D.Del. |
|
|
|
|
| 27 |
OTSUKA PHARMACEUTICAL CO., LTD. v. ALEMBIC PHARMACEUTICALS LIMITED |
1:14-cv-02982 |
D.N.J. |
|
|
|
|
| 28 |
Sanofi et al v. Watson Laboratories Inc. et al |
1:14-cv-00264 |
D.Del. |
|
|
|
|
| 29 |
Sanofi et al v. Watson Laboratories Inc. et al |
1:14-cv-00264 |
D.Del. |
|
|
|
|